Trials / Completed
CompletedNCT02849340
Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Fuda Cancer Hospital, Guangzhou · Academic / Other
- Sex
- Female
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is the safety and efficacy of cryosurgery plus NK immunotherapy to recurrent cervical cancer.
Detailed description
By enrolling patients with recurrent cervical cancer adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of the combined therapy using cryosurgery and natural killer (NK) cells. The safety will be evaluated by statistics of adverse reactions. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cryosurgery | Percutaneous ablation under CT or ultrasound guidance |
| BIOLOGICAL | NK immunotherapy | Each treatment: 8\~10 billion cells in all, transfuion in 3 times, i.v. |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2017-07-01
- Completion
- 2019-07-01
- First posted
- 2016-07-29
- Last updated
- 2019-09-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02849340. Inclusion in this directory is not an endorsement.